<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Subtitle 19 DANGEROUS DEVICES AND SUBSTANCES | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.19/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.19/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|19|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="doc-num" content="19"/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|19" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/md/exec/comar/10.19"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Subtitle 19 DANGEROUS DEVICES AND SUBSTANCES | Library of Maryland Regulations"/>
    <meta property="og:image" content="/us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.19/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.19/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|19" data-search-heading="">
                  <span title="Subtitle 19 DANGEROUS DEVICES AND SUBSTANCES">Subtitle 19 DANGEROUS DEVICES AND SUBSTANCES</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|19">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.19">Subtitle 19 DANGEROUS DEVICES AND SUBSTANCES</h1>
                <h2 id="/us/md/exec/comar/10.19.01" data-order="|10|19|01|" data-ref-path="10|19|01" class="h__chapter">Chapter 01 Prohibition of Bisphenol-A in Child Care Articles</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: November 28, 2011 (38:24 Md. R. 1502)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §24-304, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.19.01.01" data-order="|10|19|01|.01|" data-ref-path="10|19|01|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter establishes regulations that prohibit the manufacturing, sale, or distribution of child care articles that contain bisphenol-A, also known as BPA.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.01.02" data-order="|10|19|01|.02|" data-ref-path="10|19|01|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.01.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.01.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.01.02#B(1)">(1)</span> “Bisphenol-A (BPA)” means an industrial chemical also known as 2,2-bis (4-hydroxyphenyl) propane used primarily in the manufacture of polycarbonate plastic and epoxy resins.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.01.02#B(2)">(2)</span> "Child care article" means an empty bottle or cup to be filled with food or liquid that is designed or intended by a manufacturer to be used by a child younger than 4 years old.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.01.03" data-order="|10|19|01|.03|" data-ref-path="10|19|01|.03" class="h__section">.03 Prohibition of Bisphenol-A in Child Care Articles.</h3>
                <p>On or after January 1, 2012, a person may not manufacture, knowingly sell, or distribute in commerce a child care article containing bisphenol-A.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.01.04" data-order="|10|19|01|.04|" data-ref-path="10|19|01|.04" class="h__section">.04 Requirements on Manufacturers.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.01.04#A">A.</span> A manufacturer of a child care article shall use a safe and legal alternative to BPA when replacing BPA in a child care article.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.01.04#B">B.</span> A manufacturer of a child care article may not use in place of BPA a substance determined by the United States Environmental Protection Agency to be a:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.01.04#B(1)">(1)</span> Group A, B, or C carcinogen; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.01.04#B(2)">(2)</span> Reproductive toxicant causing birth defect, reproductive harm, or developmental harm.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.01.05" data-order="|10|19|01|.05|" data-ref-path="10|19|01|.05" class="h__section">.05 Violations.</h3>
                <p>A person that violates any of the provisions of Health-General Article, §24-304, Annotated Code of Maryland, is guilty of a misdemeanor and on conviction is subject to a fine not exceeding $10,000 for each violation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.19.02" data-order="|10|19|02|" data-ref-path="10|19|02" class="h__chapter">Chapter 02 Hazardous Substances</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: February 2, 1977 (4:3 Md. R. 145)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §22-502, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.19.02.01" data-order="|10|19|02|.01|" data-ref-path="10|19|02|.01" class="h__section">.01 Incorporation by Reference.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.02.01#A">A.</span> All provisions of 16 Code of Federal Regulations, Parts 1500 and 1505, are incorporated by reference, with the following changes set forth below.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.02.01#B">B.</span> 1500.3 Definitions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.02.01#B(1)">(1)</span> "Act" means the Maryland Hazardous Substance Act, Health-General Article, §22-502, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.02.01#B(2)">(2)</span> "Commission" means the Maryland Department of Health.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.19.03" data-order="|10|19|03|" data-ref-path="10|19|03" class="h__chapter">Chapter 03 Controlled Dangerous Substances</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: January 19, 1977 (4:2 Md. R. 87)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03.03#A" title="">Regulation .03A</a> amended effective December 17, 1984 (11:25 Md. R. 2134); February 17, 1992 (19:3 Md. R. 304); December 24, 2001 (28:25 Md. R. 2190)</p>
                  <p>Regulation .07E and J amended effective August 17, 1992 (19:16 Md. R. 1474)</p>
                  <p>Regulation .07H amended effective July 12, 1998 (25:14 Md. R. 1132)</p>
                  <p>Regulations .07N, R and .10B amended effective February 10, 1978 (5:3 Md. R. 138)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03.08#G" title="">Regulation .08G</a> amended effective March 30, 1992 (19:6 Md. R. 673)</p>
                  <p>Regulation .09A amended effective April 18, 1980 (7:8 Md. R. 771)</p>
                  <p>——————</p>
                  <p>Chapter revised effective April 26, 2004 (31:8 Md. R. 646)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03.03" title=".03 Definitions.">Regulation .03</a> repealed and new Regulation .03 adopted effective April 24, 2006 (33:8 Md. R. 732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03.03" title=".03 Definitions.">Regulation .03</a> amended effective January 1, 2016 (42:22 Md. R. 1377)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03.13" title=".13 Partial Fill of a Prescription.">Regulation .13</a> adopted as an emergency provision effective October 18, 2011 (38:24 Md. R. 1495); adopted permanently effective December 26, 2011 (38:26 Md. R. 1697)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03.01" title=".01 Scope and Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03.13" title=".13 Partial Fill of a Prescription.">.13</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03.01" title=".01 Scope and Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03.20" title=".20 Additional Controlled Substances in Maryland.">.20</a> adopted effective October 14, 2024 (51:20 Md. R. 899)</p>
                  <h3>Authority</h3>
                  <p>Criminal Law Article, Title 5; Health-General Article, §21-220; Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.19.03.01" data-order="|10|19|03|.01|" data-ref-path="10|19|03|.01" class="h__section">.01 Scope and Purpose.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.01#A">A.</span> The Secretary of the Maryland Department of Health recognizes that the public interest requires control over the use of controlled substances in the legitimate manufacturing, distributing, dispensing, storing, and ordering of controlled substances.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.01#B">B.</span> This chapter applies to every registrant who manufactures, distributes, dispenses, stores, and orders any controlled substances within the State of Maryland, unless exempted from registration by <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-301" title="">Criminal Law Article, §5-301(d), Annotated Code of Maryland</a>, or 21 CFR §§1301.22 — 1301.24.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.01#C">C.</span> In the event of conflict between a provision of the Code of Federal Regulations referenced under a provision of this chapter and the provision of this chapter, the registrant shall comply with the more stringent provision.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.02" data-order="|10|19|03|.02|" data-ref-path="10|19|03|.02" class="h__section">.02 Incorporation by Reference.</h3>
                <p>In this chapter, 21 CFR §§1300 —1317, as amended, are incorporated by reference.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.03" data-order="|10|19|03|.03|" data-ref-path="10|19|03|.03" class="h__section">.03 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#A">A.</span> Applicability to Chapter. In this chapter, the terms defined in <a class="internal-link " href="/us/md/exec/comar/10.19.03.03#B" title="">§B of this regulation</a> have the meanings indicated. In addition, and unless otherwise provided in this chapter, the definitions appearing in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-101" title="">Criminal Law Article, §5-101, Annotated Code of Maryland</a>, shall also apply to this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(1)">(1)</span> “Act” means the Maryland Controlled Dangerous Substances Act, Criminal Law Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-101" title="">5-101</a>—<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-1101" title="">5-1101</a>, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(2)">(2)</span> “Administrative probable cause” means a valid public interest, sufficient to justify an administrative warrant, allowing the inspection of the area, premises, or building to enforce this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(3)">(3)</span> “Agent” means a person who acts on behalf of the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(4)">(4)</span> “Authorized provider” or “provider” means a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(4)(a)">(a)</span> Person licensed, registered, or otherwise allowed to dispense, order, and store controlled substances;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(4)(b)">(b)</span> Pharmacy, laboratory, hospital, or other institution licensed, registered, or otherwise allowed to manufacture, distribute, dispense, store, and order controlled substances; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(4)(c)">(c)</span> Person licensed, registered, or otherwise allowed to conduct research on a controlled substance in the State in the course of professional practice or research.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(5)">(5)</span> “Board” means the Maryland Boards of Physicians, Podiatry, Dental Examiners, Nursing, and Veterinary Medicine.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(6)">(6)</span> “Chemical analysis” means the act of decomposing a substance into its constituent elements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(7)">(7)</span> “Civil fine” means a fine assessed by the Department against an authorized provider, including establishments.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(8)">(8)</span> Commercial Container.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(8)(a)">(a)</span> “Commercial container” means any bottle, jar, tube, ampule, or other receptacle in which a substance is held for distribution or dispensing to an ultimate user.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(8)(b)">(b)</span> “Commercial container” includes any box or package in which a receptacle is held for distribution or dispensing to an ultimate user.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(8)(c)">(c)</span> “Commercial container” does not include any package liner, package insert, or other material kept with or within a commercial container, or any carton, crate, drum, or other package in which commercial containers are stored or are used for shipment of controlled substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(9)">(9)</span> Controlled Premises.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(9)(a)">(a)</span> “Controlled premises” means places where original or other records or documents required under the Act are kept or required to be kept.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(9)(b)">(b)</span> “Controlled premises” includes factories, warehouses, other establishments, and conveyances, where persons registered under the Act or exempt from registration under the Act may lawfully hold, manufacture, distribute, dispense, administer, or otherwise dispose of controlled substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(10)">(10)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(11)">(11)</span> “Disciplinary action” includes but is not limited to a penalty, reprimand, restriction, suspension, or revocation of a license.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(12)">(12)</span> “Federal Act” means the Controlled Substance Act (84 Stat. 1242; 21 U.S.C. 801) or the Controlled Substance Import and Export Act (84 Stat. 1285; 21 U.S.C. 951).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(13)">(13)</span> “Fee exempt” means an authorized provider that is required to register with the Department but is not required to pay the registration fee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(14)">(14)</span> “In good standing” means having a professional license that is not subject to any form of sanction by the Board or Criminal Law.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(15)">(15)</span> “Inspector” means an officer or employee of the Department authorized by the Secretary to make inspections under the Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(16)">(16)</span> “Labeling” means all labels and other written, printed, or graphic matter on any controlled substance or any of its commercial containers or wrappers accompanying controlled substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(17)">(17)</span> “License” has the same meaning as <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">State Government Article, §10-226, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(18)">(18)</span> Manufacture.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(18)(a)">(a)</span> “Manufacture” means:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(18)(a)(i)">(i)</span> Producing, preparation, propagation, compounding, or processing of a drug or other substance;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(18)(a)(ii)">(ii)</span> Packaging or repackaging of the substance; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(18)(a)(iii)">(iii)</span> Labeling or re-labeling of the commercial container of the substance.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(18)(b)">(b)</span> “Manufacture” does not include the activities of a provider who, as an incident to the provider’s administration or dispensing the substance in the course of the provider’s professional practice, prepares, compounds, packages, or labels the substance.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(19)">(19)</span> “Manufacturer” means a person who manufactures a drug or other substance under:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(19)(a)">(a)</span> A registration as a manufacturer; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(19)(b)">(b)</span> Authority of registration as a researcher or chemical analyst.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(20)">(20)</span> “Office of Controlled Substances Administration (OCSA)” refers to the division within the Maryland Department of Health responsible for administering the enforcement of <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gcr/gcr.pdf" title="">Criminal Law Article, Title 5, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(21)">(21)</span> “Penalty” means monetary penalty, including but not limited to a fine.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(22)">(22)</span> “Person” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(22)(a)">(a)</span> An authorized provider;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(22)(b)">(b)</span> The responsible party listed on the application licensed by the DEA; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(22)(c)">(c)</span> The responsible party listed on the application for an establishment not licensed by the DEA.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(23)">(23)</span> “Peyote” means the controlled substance in Schedule I under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-402" title="">Criminal Law Article, §5-402, Annotated Code of Maryland</a>. This schedule I listing does not apply to the nondrug use of peyote in bona fide religious ceremonies of the Native American Church, and members of the Native American Church using peyote in this manner are exempt from registration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(24)">(24)</span> “Pharmacist” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(24)(a)">(a)</span> A pharmacist licensed in the State or otherwise authorized to dispense controlled substances; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(24)(b)">(b)</span> An individual, for example, a pharmacist intern, authorized by a state to dispense controlled substances under the supervision of a pharmacist licensed by that state.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(25)">(25)</span> Prescription.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(25)(a)">(a)</span> “Prescription” means an order for medication that is dispensed to or for an ultimate user.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(25)(b)">(b)</span> “Prescription” does not include an order for medication which is dispensed for immediate administration to the ultimate user, such as an order to dispense a drug to a bed patient for immediate administration in a hospital.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(26)">(26)</span> “Registration” means initial registration or subsequent re-registration with OCSA.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(27)">(27)</span> “Secretary” means the Secretary of the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.03#B(28)">(28)</span> “Sufficient application” means an application that is completed in full and has provided all of the information required by the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.04" data-order="|10|19|03|.04|" data-ref-path="10|19|03|.04" class="h__section">.04 Registration: Requirements and Qualifications.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#A">A.</span> Except for military and federal employees working within the scope of federal employment, a person shall register with the Department and obtain a registration certificate before the person:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#A(1)">(1)</span> Manufactures, distributes, dispenses, stores, and orders controlled substances;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#A(2)">(2)</span> Conducts research or instructional activities with controlled substances listed in Schedules II through V of Criminal Law Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-403" title="">5-403</a>—<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-406" title="">5-406</a>, Annotated Code of Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#A(3)">(3)</span> Conducts research or instructional activities with a controlled substance listed in Schedule I of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-402" title="">Criminal Law Article, §5-402, Annotated Code of Maryland</a>, with prior registration from the DEA;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#A(4)">(4)</span> Conducts a chemical analysis with controlled substances listed in any schedule;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#A(5)">(5)</span> Installs and maintains an automated dispensing machine containing controlled substances; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#A(6)">(6)</span> Manufactures peyote for, or distributes peyote to, the Native American Church for bona fide religious ceremonies of the Native American Church.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#B">B.</span> An authorized provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#B(1)">(1)</span> Apply for a registration certificate on a form made available by the Department to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#B(1)(a)">(a)</span> Obtain one registration for all locations that a provider prescribes only and no controlled substances are stored; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#B(1)(b)">(b)</span> Obtain a single registration for each separate location where the provider prescribes, dispenses, orders, and stores controlled substances;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#B(2)">(2)</span> Have a professional license in good standing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#B(3)">(3)</span> Be of good moral character;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#B(4)">(4)</span> Have no convictions for crimes of moral turpitude;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#B(5)">(5)</span> Be 18 years of age or older;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#B(6)">(6)</span> Be registered with the Prescription Drug Monitoring Program if the authorized provider is also a prescriber as defined under Health-General Article, §21-2A-04.1, Annotated Code of Maryland; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#B(7)">(7)</span> Except for researchers, have completed 2 continuing education credit hours:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#B(7)(a)">(a)</span> Prior to applying for an initial controlled substance registration occurring on or after October 1, 2018; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#B(7)(b)">(b)</span> Prior to the first renewal of a controlled substance registration occurring on or after October 1, 2018.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#C">C.</span> Continuing Education.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#C(1)">(1)</span> The continuing education shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#C(1)(a)">(a)</span> Be accredited by the Accreditation Council for Continuing Medical Education; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#C(1)(b)">(b)</span> Meet the requirements for approval by the authorized providers professional board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#C(2)">(2)</span> The continuing education shall pertain to the prescribing or dispensing of controlled substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#C(3)">(3)</span> Authorized providers shall meet the requirements of §§B and C of this regulation upon the completion of the 2 credit hours of continuing education.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#C(4)">(4)</span> Recent graduates meet the requirements of §§B and C of this regulation upon initial application if two academic course credits were issued relating to controlled substances.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D">D.</span> An establishment shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(1)">(1)</span> Apply for a registration certificate on a form made available by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(2)">(2)</span> Obtain one registration for each separate place of business, professional practice, or location where controlled substances are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(2)(a)">(a)</span> Ordered;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(2)(b)">(b)</span> Purchased;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(2)(c)">(c)</span> Administered;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(2)(d)">(d)</span> Delivered to the ultimate user;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(2)(e)">(e)</span> Stored;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(2)(f)">(f)</span> Manufactured; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(2)(g)">(g)</span> Distributed; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(3)">(3)</span> Have a professional or occupational license in good standing to perform any of the following functions related to controlled substances:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(3)(a)">(a)</span> Manufacture;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(3)(b)">(b)</span> Distribute;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(3)(c)">(c)</span> Deliver to the ultimate user;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(3)(d)">(d)</span> Administer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(3)(e)">(e)</span> Store;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(3)(f)">(f)</span> Order;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(3)(g)">(g)</span> Prescribe;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(3)(h)">(h)</span> Package;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(3)(i)">(i)</span> Label; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.04#D(3)(j)">(j)</span> Compound.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.05" data-order="|10|19|03|.05|" data-ref-path="10|19|03|.05" class="h__section">.05 Registration: Application.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#A">A.</span> A person shall complete an application to be considered for a registration certificate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B">B.</span> The applicant shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B(1)">(1)</span> Submit a completed application made available by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B(2)">(2)</span> Except for fee exempt applicants, pay the appropriate fee as set forth in <a class="internal-link " href="/us/md/exec/comar/10.19.03.06" title=".06 Registration: Fees.">Regulation .06 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B(3)">(3)</span> Unless exempt from payment of a registration fee, apply for and obtain a registration certificate;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B(4)">(4)</span> Provide an explanation for any not-applicable responses on the applications;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B(5)">(5)</span> Notify the Department of any criminal convictions related to controlled substances;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B(6)">(6)</span> Notify the Department of any actions taken on the applicant’s professional license;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B(7)">(7)</span> Have the application and accompanying documents required for registration signed by the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B(7)(a)">(a)</span> Applicant, if an individual;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B(7)(b)">(b)</span> General partner, if the applicant is a partnership; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B(7)(c)">(c)</span> Officer responsible for the applicant, if the applicant is a corporation or other entity; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B(8)">(8)</span> Provide additional documentation required by the Department pertinent to the registration, to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B(8)(a)">(a)</span> Clarify application information; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#B(8)(b)">(b)</span> Determine if the applicant meets the requirements of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#C">C.</span> New applications that are unable to be processed 6 months from the payment deposit date:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#C(1)">(1)</span> May be determined invalid;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#C(2)">(2)</span> Will not be issued a refund, unless:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#C(2)(a)">(a)</span> The payment is a duplicate; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#C(2)(b)">(b)</span> Approved by the Department; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#C(3)">(3)</span> Will require a new application to be resubmitted.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#D">D.</span> Renewal applications that are unable to be processed 45 days from the payment deposit date:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#D(1)">(1)</span> May be determined invalid;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#D(2)">(2)</span> Will not be issued a refund, unless:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#D(2)(a)">(a)</span> The payment is a duplicate; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#D(2)(b)">(b)</span> Approved by the Department; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.05#D(3)">(3)</span> Will require a new renewal application to be submitted.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.06" data-order="|10|19|03|.06|" data-ref-path="10|19|03|.06" class="h__section">.06 Registration: Fees.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#A">A.</span> An authorized provider or establishment required to obtain and maintain a registration certificate as set forth under this chapter shall pay the appropriate fees as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#A(1)">(1)</span> New registration certificate — $120;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#A(2)">(2)</span> Renewal registration certificate — $120;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#A(3)">(3)</span> Amend a registration certificate — $50;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#A(4)">(4)</span> Change of ownership fee — $144;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#A(5)">(5)</span> Duplicate registration certificate — $30; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#A(6)">(6)</span> Reinstatement — $50.00.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#B">B.</span> Applicants exempt from registration fees include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#B(1)">(1)</span> Except for contractual positions, an employee of a hospital, clinic, institution, facility, or unit operated by a local or State government agency;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#B(2)">(2)</span> An agency, excluding a State agency and its employees, for which the State is responsible for payment of the fee, provided that the exemption is approved by the Secretary; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#B(3)">(3)</span> A person included in 21 CFR §§1301.21.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#C">C.</span> Refunds and Credits.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#C(1)">(1)</span> The Secretary may not issue a credit towards or refund any registration fees to an applicant, including but not limited to, an applicant who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#C(1)(a)">(a)</span> Withdraws a registration application;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#C(1)(b)">(b)</span> Voluntarily or involuntarily ceases to manufacture, distribute, dispense, order, and store a controlled substances before a registration certificate expires; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#C(1)(c)">(c)</span> Does not complete the application as set forth in <a class="internal-link " href="/us/md/exec/comar/10.19.03.05" title=".05 Registration: Application.">Regulation .05 of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#C(2)">(2)</span> The Secretary, or the Secretary’s designee, shall review the refund request and determine if a refund of any amount is appropriate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#D">D.</span> A registrant who has lost a registration certificate is required to pay a duplicate registration fee as set forth in <a class="internal-link " href="/us/md/exec/comar/10.19.03.06#A" title="">§A of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#E">E.</span> The Department may not issue a new or a renewed registration certificate until all required fees are paid.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.06#F">F.</span> The Department-issued registration certificate shall be readily available to any agent or representative of the Secretary within the registered location.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.07" data-order="|10|19|03|.07|" data-ref-path="10|19|03|.07" class="h__section">.07 Registration: Term, Expiration, Renewal, and Reinstatement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#A">A.</span> Term. The Secretary may issue a registration certificate that is valid for not more than 3 years.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#B">B.</span> Expiration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#B(1)">(1)</span> A registration certificate expires on the date shown on the certificate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#B(2)">(2)</span> The Secretary shall notify the registrant that the registration will expire not less than 30 days before the expiration date shown on the certificate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#C">C.</span> Renewal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#C(1)">(1)</span> A registration for which a sufficient application for renewal was submitted:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#C(1)(a)">(a)</span> Shall be received at least 2 weeks before the expiration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#C(1)(b)">(b)</span> Will remain in effect until the Department takes a final action.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#C(2)">(2)</span> The failure to receive a renewal notice does not excuse a registrant from complying with this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#D">D.</span> Reinstatement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#D(1)">(1)</span> A registrant whose registration has been surrendered in lieu of further investigation, revoked, suspended, or limited may not be eligible to request reinstatement for a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#D(1)(a)">(a)</span> 2-year period;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#D(1)(b)">(b)</span> Specified period designated in a consent order from the Department; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#D(1)(c)">(c)</span> Specified time period determined by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#D(2)">(2)</span> To apply for reinstatement, a registrant shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#D(2)(a)">(a)</span> Complete and submit an application on a form provided by the Department; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.07#D(2)(b)">(b)</span> Pay a reinstatement fee shown in <a class="internal-link " href="/us/md/exec/comar/10.19.03.06" title=".06 Registration: Fees.">Regulation .06 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.08" data-order="|10|19|03|.08|" data-ref-path="10|19|03|.08" class="h__section">.08 Registration Certificate: Assignment, Transfer, or Termination.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#A">A.</span> A registration certificate is not transferable.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#B">B.</span> A registration certificate becomes void when the registrant:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#B(1)">(1)</span> Dies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#B(2)">(2)</span> Discontinues business or professional practice in the State; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#B(3)">(3)</span> Changes ownership, including when:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#B(3)(a)">(a)</span> Partners are added or deleted from the partnership;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#B(3)(b)">(b)</span> There is a change in the president or chief executive officer of the corporation; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#B(3)(c)">(c)</span> There is a change in the ownership of 10 percent or more of the outstanding shares in the corporation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#C">C.</span> A registrant who discontinues business or professional practice in the State shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#C(1)">(1)</span> Notify the Secretary in writing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#C(2)">(2)</span> Surrender the registrant’s current registration certificate; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#C(3)">(3)</span> Legally transfer or dispose of any controlled substances relative to the registrant’s operation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#D">D.</span> A registrant who changes ownership of the business or professional practice shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#D(1)">(1)</span> Notify the Secretary in writing at least 30 days before the change occurs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#D(2)">(2)</span> Complete and submit a change of ownership application to the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#D(3)">(3)</span> Pay the change-of-ownership fee in <a class="internal-link " href="/us/md/exec/comar/10.19.03.06" title=".06 Registration: Fees.">Regulation .06 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#D(4)">(4)</span> Surrender the registrant’s current registration certificate after the ownership change is finalized; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#D(5)">(5)</span> Allow the Department to inspect the business or professional practice of the new owners.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#E">E.</span> A registrant who changes the location of a registrant’s place of business or professional practice shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#E(1)">(1)</span> Notify the Department at least 30 days before there is a change in the location of the registrant’s place of business or professional practice;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#E(2)">(2)</span> Apply to amend a current registration certificate; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#E(3)">(3)</span> Pay the fee to amend a certificate in <a class="internal-link " href="/us/md/exec/comar/10.19.03.06" title=".06 Registration: Fees.">Regulation .06 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#F">F.</span> During the 3-year registration period, the registrant shall notify the Office of Controlled Substances Administration within 30 days of the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#F(1)">(1)</span> Any criminal convictions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#F(2)">(2)</span> Any disciplinary actions taken against the registrant’s professional or occupational license; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#F(3)">(3)</span> Any disciplinary actions taken against the registrant’s federal Drug Enforcement Agency registration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#G">G.</span> After an application for registration has been filed, the Secretary may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#G(1)">(1)</span> Inspect the place of business or professional practice described in the application; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#G(2)">(2)</span> Investigate the applicant to determine whether the applicant meets the requirements of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.08#H">H.</span> The registrant shall inform the Office of Controlled Substances Administration prior to any address changes.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.09" data-order="|10|19|03|.09|" data-ref-path="10|19|03|.09" class="h__section">.09 Labeling and Packaging Requirements for Controlled Substances.</h3>
                <p>A registrant shall comply with the provisions of 21 CFR §1302, as amended.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.10" data-order="|10|19|03|.10|" data-ref-path="10|19|03|.10" class="h__section">.10 Records and Reports Required of Registrants.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.10#A">A.</span> Pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-306" title="">Criminal Law Article, §5-306, Annotated Code of Maryland</a>, a registrant shall comply with the provisions of 21 CFR §1304, as amended.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.10#B">B.</span> Inventories developed under the Federal Act dated May 1, 1971, and subsequent biennial inventory dates are acceptable for purposes of the Maryland Act.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.10#C">C.</span> On the effective date a substance is added to any schedule of controlled substances pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-202" title="">Criminal Law Article, §5-202, Annotated Code of Maryland</a>, registrants required to keep records, who possess that substance, shall take an inventory of all stocks of that substance on hand.  Thereafter, that substance shall be included in each inventory made by the registrant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.10#D">D.</span> Reports required in this section shall be accessible to the representative of the Secretary.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.11" data-order="|10|19|03|.11|" data-ref-path="10|19|03|.11" class="h__section">.11 Order Forms.</h3>
                <p>A registrant shall comply with the provisions of 21 CFR 1305, as amended.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.12" data-order="|10|19|03|.12|" data-ref-path="10|19|03|.12" class="h__section">.12 Prescriptions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#A">A.</span> Persons Entitled to Issue Prescriptions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#A(1)">(1)</span> A prescription for a controlled substance may be issued only by an authorized provider who is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#A(1)(a)">(a)</span> Authorized to prescribe controlled substances in the State of Maryland; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#A(1)(b)">(b)</span> Either registered or exempted from registration pursuant to 21 CFR §1301.22(c) and 21 CFR §1301.23.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#A(2)">(2)</span> A prescription issued by an authorized provider may be communicated to a pharmacist by an employee or agent of the authorized provider.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#B">B.</span> Purpose of Issue of Prescription.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#B(1)">(1)</span> A controlled substance prescription shall only be issued for a legitimate medical purpose by a provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#B(2)">(2)</span> A controlled substance prescription shall be issued by a provider in the usual course of the individual provider’s professional practice.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#B(3)">(3)</span> The responsibility for the proper prescribing and dispensing of controlled substances is upon the prescribing provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#B(4)">(4)</span> A pharmacist has a corresponding responsibility to ensure, prior to dispensing, that a controlled substance prescription is issued for a legitimate medical purpose.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#B(5)">(5)</span> An order purporting to be a prescription issued not in the usual course of professional treatment or in legitimate and authorized research is not a prescription within the meaning and intent of the Maryland Controlled Dangerous Substances Act, Criminal Law Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-501" title="">5-501</a>—<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-505" title="">5-505</a>, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#B(6)">(6)</span> A prescription may not be issued in order for an individual provider to obtain controlled substances for supplying the individual provider for the purpose of general dispensing to patients.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#C">C.</span> A prescription for a Schedule II-V controlled substance shall be dispensed within 120 days from the date of issue.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.12#D">D.</span> Unless the State has stricter requirements, if a provider has complied with 21 CFR §1306, the provider is deemed to have complied with this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.13" data-order="|10|19|03|.13|" data-ref-path="10|19|03|.13" class="h__section">.13 Partial Fill of a Prescription.</h3>
                <p>A partial fill of a C-II prescription is permitted if:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.13#A">A.</span> The pharmacist is unable to fill the full quantity of the prescription, pursuant to 21 CFR §1306.13(a);</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.13#B">B.</span> The prescription is issued for a patient in a long-term care facility or for a patient with a medical diagnosis documenting a terminal illness pursuant to 21 CFR 1306.13(b) or (c);</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.13#C">C.</span> Requested by the patient or the practitioner that wrote the prescription, pursuant to 21 CFR §1306.13(b); or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.13#D">D.</span> The total quantity dispensed in all partial fillings does not exceed the total quantity prescribed.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.14" data-order="|10|19|03|.14|" data-ref-path="10|19|03|.14" class="h__section">.14 Refilling of Prescriptions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#A">A.</span> A prescription for a controlled substance listed in Schedule II may not be refilled.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#B">B.</span> A prescription for a controlled substance listed in Schedule III, IV, or V:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#B(1)">(1)</span> May not be refilled more than 6 months after the date on which the prescription was issued;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#B(2)">(2)</span> May not be refilled more than five times; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#B(3)">(3)</span> Shall require a new and separate prescription to be issued if additional quantities are deemed necessary by the authorized prescribing provider.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#C">C.</span> The prescribing provider may authorize additional refills of Schedule III, IV, or V substances on the original prescription through an oral refill authorization transmitted to the pharmacist if the following conditions are met:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#C(1)">(1)</span> The total quantity authorized, including the amount of the original prescription, does not exceed five refills or extend beyond 6 months from the date of issue of the original prescription;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#C(2)">(2)</span> The pharmacist obtaining the oral authorization records on the reverse of the original paper prescription or annotates the electronic prescription record with the date, quantity of refill, and number of additional refills authorized, and initials the paper prescription or annotates the electronic prescription record showing who received the authorization from the prescribing practitioner who issued the original prescription;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#C(3)">(3)</span> The quantity of each additional refill authorized is equal to or less than the quantity authorized for the initial filling of the original prescription; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#C(4)">(4)</span> The prescribing practitioner executes a new and separate prescription for any additional quantities beyond the five-refill, 6-month limitation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D">D.</span> Required Documentation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(1)">(1)</span> Each refilling of a prescription shall be documented on the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(1)(a)">(a)</span> Back of the prescription;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(1)(b)">(b)</span> With Department approval, on another appropriate uniformly maintained, readily retrievable record, such as medication records; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(1)(c)">(c)</span> electronic prescription record.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(2)">(2)</span> The documentation shall indicate the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(2)(a)">(a)</span> Number of the prescription;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(2)(b)">(b)</span> Name of the controlled substance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(2)(c)">(c)</span> Dosage form of the controlled substance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(2)(d)">(d)</span> Date of each refilling;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(2)(e)">(e)</span> Quantity dispensed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(2)(f)">(f)</span> Identity or initials of the dispensing pharmacist in each refilling;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(2)(g)">(g)</span> Total number of refills for that prescription;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(2)(h)">(h)</span> Pharmacist’s initials; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(2)(i)">(i)</span> Date by the pharmacist as of the date of dispensing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(3)">(3)</span> Each refilling of a prescription shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(3)(a)">(a)</span> State the amount dispensed; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.14#D(3)(b)">(b)</span> If the amount dispensed is not specifically stated, be deemed to have been dispensed for the full face amount of the prescription.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.15" data-order="|10|19|03|.15|" data-ref-path="10|19|03|.15" class="h__section">.15 Physical Security Controls for Registrants.</h3>
                <p>A registrant shall comply with the provisions of 21 CFR §§1301.71—1301.77 as amended.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.16" data-order="|10|19|03|.16|" data-ref-path="10|19|03|.16" class="h__section">.16 Controlled Substance Disposal.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#A">A.</span> Any registrant in possession of legally obtained controlled substances and desiring or required to dispose of any of these substances may ask the Office of Controlled Substances Administration of the Maryland Department of Health for authority and instructions to dispose of this substance. This does not eliminate the requirement on registrants under federal regulations to report destruction of controlled dangerous substances.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#B">B.</span> Disposal of Medical Waste.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#B(1)">(1)</span> A registrant in possession of legally obtained controlled substances deemed medical waste shall render the controlled substances irretrievable by disposing of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#B(1)(a)">(a)</span> Liquid waste in an approved containment unit; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#B(1)(b)">(b)</span> Non-liquid in a receptacle.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#B(2)">(2)</span> Two licensed personnel shall keep Waste Destruction Logbooks and maintain the record for 2 years. The Destruction Log shall be readily available upon inspection.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#C">C.</span> Disposal for Registrants Required to Register with the DEA.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#C(1)">(1)</span> The Office of Controlled Substances Administration shall authorize and instruct the registrant to dispose of the controlled substance in one of the following manners, provided complete records of the disposition are maintained by the registrant:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#C(1)(a)">(a)</span> By transfer to a person registered under the Act and authorized to possess the substance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#C(1)(b)">(b)</span> By destruction in the presence of an agent of the Office of Controlled Substances Administration or another authorized person;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#C(1)(c)">(c)</span> By forwarding to the District Office of the Drug Enforcement Administration pursuant to the procedures of that agency;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#C(1)(d)">(d)</span> By returning unused controlled substances dispensed by registered hospital pharmacies for administration to in-patients to the pharmacy for appropriate disposition; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#C(1)(e)">(e)</span> By other means that the Secretary may determine to assure that the substance does not become available to unauthorized persons.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#C(2)">(2)</span> A registrant that has complied with 21 CFR §1304 is deemed to have complied with this section.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#C(3)">(3)</span> If a registrant is required regularly to dispose of controlled substances, the Special Agent in Charge of the Federal Drug Enforcement Administration may authorize the registrant to dispose of these substances, in accordance with 21 CFR §1307.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#D">D.</span> Disposal for Registrants Not required to Register with the DEA. Any registrant who is registered to administer only and is in possession of legally obtained controlled substances shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#D(1)">(1)</span> List the controlled substance or substances which the registrant desires to dispose of on a drug destruction form provided by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#D(2)">(2)</span> Have two members of the professional staff, limited to an administrator, nurse, or pharmacist, destroy controlled drugs on premises;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#D(3)">(3)</span> Dispose per instructions given in <a class="internal-link " href="/us/md/exec/comar/10.19.03.16#B" title="">§B of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#D(4)">(4)</span> Forward a copy of the completed drug destruction form to the Office of Controlled Substances Administration within 10 days of destruction; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#D(5)">(5)</span> Keep a copy of the drug disposal form on location for a period of 2 years.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#E">E.</span> Abandoned controlled substances may be:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#E(1)">(1)</span> Destroyed in the presence of an agent of the Office of Controlled Substances Administration or another authorized person or persons;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#E(2)">(2)</span> Disposed of by other means that the Secretary may determine to assure that the substance does not become available to unauthorized persons; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#E(3)">(3)</span> Impounded under Health-General Article, §21-1113, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.16#F">F.</span> Aforementioned procedures do not preclude release of medication to discharged patients if ordered in writing by the attending physician.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.17" data-order="|10|19|03|.17|" data-ref-path="10|19|03|.17" class="h__section">.17 Transfer of Controlled Substances.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#A">A.</span> When closing business activities, a registrant shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#A(1)">(1)</span> Dispose of all controlled dangerous substances in accordance with <a class="internal-link " href="/us/md/exec/comar/10.19.03.16" title=".16 Controlled Substance Disposal.">Regulation .16 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#A(2)">(2)</span> Return the controlled substances registration certificate to the Office of Controlled Substances Administration inspector at the time of the closing inspection.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B">B.</span> Change of Ownership.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(1)">(1)</span> A Change of Ownership requires the registrant to notify the Department in writing, Attention to the Office of Controlled Substances Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(2)">(2)</span> The written notification shall be submitted:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(2)(a)">(a)</span> In person;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(2)(b)">(b)</span> By registered mail; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(2)(c)">(c)</span> By certified mail with a return receipt request.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(3)">(3)</span> The written notification must be received 14 days before the transfer occurs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(4)">(4)</span> The Secretary has the authority to waive the 14-day time limitation in individual instances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(5)">(5)</span> The written notification shall contain the following information:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(5)(a)">(a)</span> The name;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(5)(b)">(b)</span> The address;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(5)(c)">(c)</span> The registration number; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(5)(d)">(d)</span> The authorized business activity of the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(5)(d)(i)">(i)</span> Registrant-transferor discontinuing the business; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(5)(d)(ii)">(ii)</span> Registrant-transferee acquiring the business;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(5)(e)">(e)</span> Whether the business activities will be:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(5)(e)(i)">(i)</span> Continued at the location registered by the person discontinuing business; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(5)(e)(ii)">(ii)</span> Moved to another location and, if so, the address of the new location; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(5)(f)">(f)</span> The date on which the transfer of controlled substances will occur.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(6)">(6)</span> Except for transfer denials by the Secretary, the registrant-transferor may distribute, without being registered to distribute, controlled substances in the registrant-transferor’s possession to the registrant-transferee in accordance with the following procedures, on the date of transfer of the controlled substances:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(6)(a)">(a)</span> A complete inventory of all controlled substances being transferred shall be taken and serve as the final inventory of the registrant-transferor and the initial inventory of the registrant-transferee;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(6)(b)">(b)</span> A copy of the inventory shall be included in the records of both the transferor and transferee;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(6)(c)">(c)</span> A copy of the inventory shall be filed with the Department if requested by the Secretary;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(6)(d)">(d)</span> Transfers of Schedule I or II controlled substances shall require the use of order forms in accordance with 21 CFR §1305;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(6)(e)">(e)</span> All transferor-controlled substance records shall be transferred to the transferee; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.17#B(6)(f)">(f)</span> Pursuant to 21 CFR §1304, transferors are required to make reports, which shall be marked as “Final”.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.18" data-order="|10|19|03|.18|" data-ref-path="10|19|03|.18" class="h__section">.18 Administrative Inspections and Warrants.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A">A.</span> Administrative Inspections.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(1)">(1)</span> Procedures regarding administrative inspections and warrants pursuant to Criminal Law Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-305" title="">5-305</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-804" title="">5-804</a>, and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-805" title="">5-805</a>, Annotated Code of Maryland, are governed generally by those sections of the Annotated Code and specifically by this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(2)">(2)</span> Authority to make inspections is authorized in accordance with Criminal Law Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-804" title="">5-804</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-805" title="">5-805</a>, Annotated Code of Maryland, to enter controlled premises and conduct administrative inspections for the purpose of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(2)(a)">(a)</span> Documents required to be kept or made pursuant to 21 CFR §1304, under the Act, or regulations promulgated under the Act may be:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(2)(a)(i)">(i)</span> Inspected;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(2)(a)(ii)">(ii)</span> Copied;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(2)(a)(iii)">(iii)</span> Verified for correctness; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(2)(a)(iv)">(iv)</span> Inventoried;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(2)(b)">(b)</span> Collecting samples of controlled substances or precursors (if samples are collected during an inspection, the inspector shall issue a receipt for these samples to the owner, operator, or agent in charge of the premises);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(2)(c)">(c)</span> Review of records and information on the distribution of controlled substances by the authorized provider;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(2)(d)">(d)</span> Reviewing the authorized providers processes;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(2)(e)">(e)</span> Reviewing the authorized providers controls; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(2)(f)">(f)</span> Inspecting the authorized providers facility operations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(3)">(3)</span> Entry.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(3)(a)">(a)</span> An inspection shall be carried out by an inspector.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(3)(b)">(b)</span> An inspector shall have the right to enter the premises and conduct inspections at reasonable times and in a reasonable manner, upon the following conditions:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(3)(b)(i)">(i)</span> Stating the inspector’s purpose; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(3)(b)(ii)">(ii)</span> Presenting to the owner, operator, or agent in charge of the premises to be inspected, appropriate credentials and written notice of the inspector’s inspection authority under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-305" title="">Criminal Law Article, §5-305, </a>5-804, or 5-805, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(4)">(4)</span> Consent to Inspection of Financial Data, Sales Data Other than Shipment Data, or Pricing Data.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(4)(a)">(a)</span> If inspection is desired of financing, sales, or pricing data, written consent shall first be obtained from the owner, operator, or agent in charge of the premises to be inspected.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(4)(b)">(b)</span> This written consent shall contain the following information:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(4)(b)(i)">(i)</span> That the owner, operator, or agent in charge has the right to refuse to consent to an inspection of these items;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(4)(b)(ii)">(ii)</span> That anything of an incriminating nature which may be found may be seized and used against the owner, operator, or agent in charge in a criminal prosecution;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(4)(b)(iii)">(iii)</span> That the owner, operator, or agent in charge has been presented with a notice of inspection;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(4)(b)(iv)">(iv)</span> That the consent is given by the owner, operator, or agent in charge voluntarily and without threats of any kind; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(4)(b)(v)">(v)</span> That the owner, operator, or agent in charge may withdraw the owner’s, operator’s, or agent in charge’s consent at any time during the course of inspection.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(4)(c)">(c)</span> The written consent shall be produced in duplicate and be distributed as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(4)(c)(i)">(i)</span> The original will be retained by the inspector; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#A(4)(c)(ii)">(ii)</span> The duplicate will be given to the authorized provider inspected.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#B">B.</span> Administrative Warrants.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#B(1)">(1)</span> Probable Cause. If the Department is satisfied that administrative probable cause exists, the Department shall issue an administrative warrant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#B(2)">(2)</span> Execution of Warrants. An administrative inspection warrant shall be executed as required by <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-804" title="">Criminal Law Article, §5-804(d), Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.18#B(3)">(3)</span> Refusal to Allow Inspection with an Administrative Warrant. If an authorized provider or any person subject to the Act refuses to permit execution of an administrative warrant, or impedes the inspector in the execution of that warrant, the authorized provider or person shall be advised that this refusal or action constitutes a violation of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-902" title="">Criminal Law Article, §5-902(a)(3), Annotated Code of Maryland</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.19" data-order="|10|19|03|.19|" data-ref-path="10|19|03|.19" class="h__section">.19 Hearings, Enforcement, and Disciplinary Sanctions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#A">A.</span> Authority for Enforcement Proceeding.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#A(1)">(1)</span> A hearing may be ordered or granted by the Secretary, at the Secretary’s discretion, to permit any person against whom criminal or civil action is contemplated under the Controlled Dangerous Substances Act an opportunity to present the individual’s views and the individual’s proposals for bringing the individual’s alleged violations into compliance with the law. The hearing will also permit the individual to show cause why prosecution should not be instituted, or to present the individual’s views on the contemplated proceeding.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#A(2)">(2)</span> The rules of procedure for hearings before the Secretary of the Maryland Department of Health shall be governed by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.01.03" title="Chapter 03 Procedures for Hearings Before the Secretary of Health">COMAR 10.01.03</a> and State Government Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-201" title="">10-201</a>—<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">10-226</a>, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#A(3)">(3)</span> Administrative Hearings. Procedures for administrative hearings shall be governed by the rules set forth in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-308" title="">Criminal Law Article, §5-308, </a>if applicable, Health-General Article, §2-207, and State Government Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-201" title="">10-201</a>—<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">10-226</a>, Annotated Code of Maryland, and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.01.03" title="Chapter 03 Procedures for Hearings Before the Secretary of Health">COMAR 10.01.03</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#B">B.</span> After a hearing pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-308" title="">Criminal Law Article, §5-308, </a>if applicable, and State Government Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-201" title="">10-201</a>—<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">10-226</a>, Annotated Code of Maryland, and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.01.03" title="Chapter 03 Procedures for Hearings Before the Secretary of Health">COMAR 10.01.03</a>, the Secretary may impose a sanction or penalty against any registrant that possesses a Maryland-issued controlled substances registration pursuant to Criminal Law Article, Title V, Annotated Code of Maryland, instead of or in addition to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#B(1)">(1)</span> The denial of an application;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#B(2)">(2)</span> The refusal to renew a registration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#B(3)">(3)</span> Suspending a registration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#B(4)">(4)</span> Revoking a registration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#B(5)">(5)</span> Placing restrictions on a registration pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-307" title="">Criminal Law Article, §5-307, Annotated Code of Maryland</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#B(6)">(6)</span> Issuing a nonpublic advisory letter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#C">C.</span> Imposition of Monetary Penalty.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#C(1)">(1)</span> After a hearing pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-308" title="">Criminal Law Article, §5-308, Annotated Code of Maryland</a>, the Department may impose a monetary penalty against a controlled substance registration holder pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-908" title="">Criminal Law Article, §5-908, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#C(2)">(2)</span> The monetary penalty may be imposed instead of or in addition to the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#C(2)(a)">(a)</span> Suspension of the controlled substances registration;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#C(2)(b)">(b)</span> Revocation of the controlled substances registration; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#C(2)(c)">(c)</span> Restrictions placed on the controlled substances registration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#C(3)">(3)</span> The monetary penalty shall be paid within 30 calendar days of the order, unless the order specifies otherwise.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#C(4)">(4)</span> Until the imposed fine is paid, the registration may not be:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#C(4)(a)">(a)</span> Restored;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#C(4)(b)">(b)</span> Reinstated; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#C(4)(c)">(c)</span> Renewed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#C(5)">(5)</span> In its discretion, the Department may refer all cases of delinquent payment to the Central Collection Unit of the Department of Budget and Management for collection.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#D">D.</span> Notwithstanding the guidelines set forth in this chapter, in order to resolve a pending disciplinary action, the Department and the registrant may agree to a surrender of a registration, or a consent order with terms, sanction, and penalties agreed to by the Department and the registrant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.19#E">E.</span> Nothing in this chapter prohibits the Department from staying any period of non-active suspension.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.03.20" data-order="|10|19|03|.20|" data-ref-path="10|19|03|.20" class="h__section">.20 Additional Controlled Substances in Maryland.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.20#A">A.</span> The following substance, also known as a “bath salt”, is added to the Maryland Controlled Dangerous Substances Act, Schedule I of the <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-402" title="">Criminal Law Article, §5-402, Annotated Code of Maryland</a>: F. 4-Methoxymethcathinone (Methedrone, bk-PMMA, PMMC).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.03.20#B">B.</span> The following substances are added to the Maryland Controlled Dangerous Substances Act, Schedule III of the <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-404" title="">Criminal Law Article, §5-404, Annotated Code of Maryland</a>:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.20#B(1)">(1)</span> Butalbital, Acetaminophen, caffeine C-III Fioricet®; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.03.20#B(2)">(2)</span> Opium &lt; or = 100mg per 100Gm or 100ml or not more than 5mg per dosage unit C-III.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.19.04" data-order="|10|19|04|" data-ref-path="10|19|04" class="h__chapter">Chapter 04 Prohibition of Smoking in Indoor Areas Open to the Public</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: April 21, 1978 (5:8 Md. R. 594)</p>
                  <p>Regulation .02W-1 adopted as an emergency provision effective March 26, 1979 (6:7 Md. R. 575); adopted permanently effective June 29, 1979 (6:13 Md. R. 1128)</p>
                  <p>Regulation .02PP amended as an emergency provision effective September 11, 1978 (5:9 Md. R. 1442), expired January 20, 1979; adopted permanently effective February 26, 1979 (6:4 Md. R. 277)</p>
                  <p>Regulation .02QQQ amended as an emergency provision effective April 27, 1979 (6:10 Md. R. 839) (Emergency provisions are temporary and not printed in COMAR)</p>
                  <p>Chapter revised effective May 16, 1980 (7:10 Md. R. 952)</p>
                  <p>——————</p>
                  <p>Chapter revised effective November 23, 1981 (8:23 Md. R. 1856)</p>
                  <p>Chapter, Drug Formulary of Equivalent Drug Products, repealed effective May 16, 1988 (15:10 Md. R. 1202)</p>
                  <p>——————</p>
                  <p>Chapter, Tobacco Smoking in Retail Stores, adopted effective February 4, 1991 (18:2 Md. R. 149)</p>
                  <p>——————</p>
                  <p>Chapter, Tobacco Smoking in Retail Stores, repealed, and new Chapter, Prohibition of Smoking in Indoor Areas Open to the Public, adopted effective February 1, 2008 (34:26 Md. R. 2262)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§24-205 and 24-501 — 24-511, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.19.04.01" data-order="|10|19|04|.01|" data-ref-path="10|19|04|.01" class="h__section">.01 Scope.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.01#A">A.</span> This chapter establishes regulations that preserve and improve the health, comfort, and environment of the people of the State by protecting the public and employees from involuntary exposure to environmental tobacco smoke in indoor areas open to the public, except for those covered by Health-General Article, §24-205, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.01#B">B.</span> Nothing in this chapter preempts a county or municipal government from enacting and enforcing more stringent measures to protect the public from involuntary exposure to environmental tobacco smoke in indoor areas open to the public.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.04.02" data-order="|10|19|04|.02|" data-ref-path="10|19|04|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(1)">(1)</span> "Act" means the Clean Indoor Air Act of 2007, Health-General Article, Title 24, Subtitle 5, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(2)">(2)</span> "Club" means a club as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=2B&amp;section=1-102" title="">Article 2B, §1-102(a)(4), Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(3)">(3)</span> "Day care transportation" means the use of a vehicle owned, operated, or contracted for by a licensed day care facility to transport the facility's clients.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(4)">(4)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(5)">(5)</span> "Environmental tobacco smoke" means the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(5)(a)">(a)</span> Complex mixture formed from the escaping smoke of a burning tobacco product; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(5)(b)">(b)</span> Smoke exhaled by a smoker.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(6)">(6)</span> "Establishment" means a single physical location where business is conducted or where services are performed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(7)">(7)</span> "Health care transportation" means transportation of patients for medical care in a vehicle owned, operated, or contracted for by a licensed health care facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(8)">(8)</span> "Health officer" means the health officer of each of the 23 counties and the Commissioner of Health in Baltimore City, the duly designated representative of the health officer, or both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(9)">(9)</span> "Indoor area" means all space in a structure or building with a ceiling that is enclosed on all sides by any combination of permanent or temporary walls, windows, or doorways, whether open or closed, or other physical barriers extending from floor to the ceiling.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(10)">(10)</span> "Indoor area open to the public" means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(10)(a)">(a)</span> An indoor area or a portion of an indoor area accessible to the public by either invitation or permission; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(10)(b)">(b)</span> An indoor area of an establishment licensed or permitted under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/2B/2B.pdf" title="">Article 2B, Annotated Code of Maryland</a>, for the sale or possession of alcoholic beverages.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(11)">(11)</span> "Owner" means an individual or entity having an ownership interest in an establishment or vehicle.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(12)">(12)</span> "Person in charge" means an owner, operator, manager, or other person who controls, governs, or directs the activities of an establishment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(13)">(13)</span> "Public transportation of children" means the transportation of children in a vehicle owned, operated, or contracted for by a government entity or a private educational institution.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(14)">(14)</span> "Secretary" means the Secretary of Health or the Secretary's designee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(15)">(15)</span> "Smoking" means the burning of a lighted cigarette, cigar, pipe, or another matter or substance that contains tobacco.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.02#B(16)">(16)</span> "Tobacco-containing product" includes bidis, cigarettes, cigars, cigarillos, kreteks, pipes, or another product or device that contains tobacco.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.04.03" data-order="|10|19|04|.03|" data-ref-path="10|19|04|.03" class="h__section">.03 Exclusions.</h3>
                <p>This chapter does not apply to:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.03#A">A.</span> Private homes and residences, including a residence used as a business or place of employment, unless being used by a person who is licensed or registered under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gfl/gfl.pdf" title="">Family Law Article, Title 5, Subtitle 5, Annotated Code of Maryland</a>, to provide day care or child care;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.03#B">B.</span> Private vehicles, unless being used:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.03#B(1)">(1)</span> For the public transportation of children; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.03#B(2)">(2)</span> As part of health care or day care transportation;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.03#C">C.</span> A hotel or motel room rented to one or more guests, if the total percent of hotel or motel rooms being rented where smoking is allowed, does not exceed 25 percent of the guest rooms in the hotel or motel;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.03#D">D.</span> A retail tobacco business that is a sole proprietorship, limited liability company, corporation, partnership, or other enterprise, in which:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.03#D(1)">(1)</span> The primary activity is the retail sale of tobacco-containing products and accessories; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.03#D(2)">(2)</span> The sale of other products is incidental;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.03#E">E.</span> A facility of a manufacturer, importer, wholesaler, or distributor of tobacco-containing products or a tobacco leaf dealer or processor in which employees of the manufacturer, importer, wholesaler, distributor, or processor work or congregate; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.03#F">F.</span> A research or educational laboratory in which smoking is conducted as a part of scientific research into:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.03#F(1)">(1)</span> The health effects of tobacco smoke; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.03#F(2)">(2)</span> The ability of a cigarette to meet fire safety standards.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.04.04" data-order="|10|19|04|.04|" data-ref-path="10|19|04|.04" class="h__section">.04 Prohibition of Smoking.</h3>
                <p>Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.19.04.03" title=".03 Exclusions.">Regulation .03 of this chapter</a>, an individual may not smoke in:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.04#A">A.</span> An indoor area open to the public;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.04#B">B.</span> An indoor place in which a meeting is open to the public in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gsg/gsg.pdf" title="">State Government Article, Title 10, Subtitle 5, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.04#C">C.</span> An indoor place of employment;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.04#D">D.</span> A government-owned or government-operated means of mass transportation, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.04#D(1)">(1)</span> Buses;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.04#D(2)">(2)</span> Vans;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.04#D(3)">(3)</span> Trains;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.04#D(4)">(4)</span> Taxicabs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.04#D(5)">(5)</span> Limousines;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.04#E">E.</span> A private home or residence that is being used by a person who is licensed or registered under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gfl/gfl.pdf" title="">Family Law Article, Title 5, Subtitle 5, Annotated Code of Maryland</a>, to provide day care or child care; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.04#F">F.</span> A private vehicle while it is being used:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.04#F(1)">(1)</span> For the public transportation of children; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.04#F(2)">(2)</span> As part of health care or day care transportation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.04.05" data-order="|10|19|04|.05|" data-ref-path="10|19|04|.05" class="h__section">.05 Owner Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.05#A">A.</span> The owner of a bar, club as defined in <a class="internal-link " href="/us/md/exec/comar/10.19.04.02#B(2)" title="">Regulation .02B(2) of this chapter</a>, restaurant, pub, tavern, retail establishment, theater, concert hall, athletic facility, financial service institution, government building, educational institution, museum, or library shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.05#A(1)">(1)</span> Prohibit smoking in an indoor area open to the public; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.05#A(2)">(2)</span> Post a sign indicating where smoking is prohibited as set forth in <a class="internal-link " href="/us/md/exec/comar/10.19.04.06#A" title="">Regulation .06A of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.05#B">B.</span> An owner of a hotel or motel shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.05#B(1)">(1)</span> Prohibit smoking in an indoor area open to the public except where smoking is permitted under <a class="internal-link " href="/us/md/exec/comar/10.19.04.03#C" title="">Regulation .03C of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.05#B(2)">(2)</span> Post a sign indicating where smoking is permitted or prohibited, as set forth in Regulation .06B and C of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.05#C">C.</span> An owner of a vehicle listed in <a class="internal-link " href="/us/md/exec/comar/10.19.04.04#D" title="">Regulation .04D of this chapter</a> shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.05#C(1)">(1)</span> Prohibit smoking in the vehicle; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.05#C(2)">(2)</span> Post a sign indicating where smoking is prohibited as set forth in <a class="internal-link " href="/us/md/exec/comar/10.19.04.06#D" title="">Regulation .06D of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.05#D">D.</span> An owner of an establishment containing an indoor area open to the public not listed in Regulation .05A — C of this chapter shall prohibit smoking in an indoor area open to the public.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.04.06" data-order="|10|19|04|.06|" data-ref-path="10|19|04|.06" class="h__section">.06 Posting of Signs.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#A">A.</span> An indoor area open to the public and every public entrance to an indoor area open to the public where smoking is prohibited under <a class="internal-link " href="/us/md/exec/comar/10.19.04.05#A" title="">Regulation .05A of this chapter</a> shall display conspicuously a "NO SMOKING" sign that conforms to the requirements of <a class="internal-link " href="/us/md/exec/comar/10.19.04.06#E" title="">Regulation .06E of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#B">B.</span> A hotel or motel room in which smoking is permitted shall display a sign containing the words "SMOKING PERMITTED IN THIS ROOM" conforming to the following requirements:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#B(1)">(1)</span> The words "SMOKING PERMITTED IN THIS ROOM" are in capital letters;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#B(2)">(2)</span> The background and the print are in contrasting colors; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#B(3)">(3)</span> The letters "SMOKING PERMITTED IN THIS ROOM" on the sign are a minimum of 1 inch in height.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#C">C.</span> An indoor area open to the public and every public entrance to an indoor area open to the public where smoking is prohibited in a hotel or motel shall display conspicuously a "NO SMOKING" sign that conforms to the requirements of <a class="internal-link " href="/us/md/exec/comar/10.19.04.06#E" title="">Regulation .06E of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#D">D.</span> A vehicle where smoking is prohibited under <a class="internal-link " href="/us/md/exec/comar/10.19.04.04#D" title="">Regulation .04D of this chapter</a> shall display conspicuously a "NO SMOKING" sign that conforms to the requirements of <a class="internal-link " href="/us/md/exec/comar/10.19.04.06#E" title="">Regulation .06E of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#E">E.</span> A "NO SMOKING" sign:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#E(1)">(1)</span> Shall contain:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#E(1)(a)">(a)</span> The words "NO SMOKING";</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#E(1)(b)">(b)</span> The international symbol for "No Smoking", consisting of a pictorial representation of a burning cigarette enclosed in a circle with a bar across the circle; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#E(1)(c)">(c)</span> A combination of the words "NO SMOKING" and the international symbol for "No Smoking"; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#E(2)">(2)</span> May contain additional information, such as:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#E(2)(a)">(a)</span> The words, "For information on quitting smoking, call 1-800-QUIT NOW (1-800-784-8669)"; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#E(2)(b)">(b)</span> The words "WARNING: TOBACCO SMOKE CAUSES CANCER AND HEART DISEASE AND CAN HARM YOUR CHILD."</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.06#F">F.</span> The owner or person in charge shall ensure that a sign required under this regulation is conspicuously posted and in good condition.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.04.07" data-order="|10|19|04|.07|" data-ref-path="10|19|04|.07" class="h__section">.07 Complaints and Investigations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.07#A">A.</span> A person may register a complaint of a violation of a requirement of this chapter by means of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.07#A(1)">(1)</span> A written complaint to the health officer in the jurisdiction where the alleged violation took place; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.07#A(2)">(2)</span> A telephone complaint to the health officer in the jurisdiction where the alleged violation took place.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.07#B">B.</span> The Department shall make available a complaint form at the Department's website and at a local health department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.07#C">C.</span> Upon receipt of a complaint, the health officer or the health officer's designee shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.07#C(1)">(1)</span> Record the complaint on the complaint form; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.07#C(2)">(2)</span> Investigate the complaint.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.04.08" data-order="|10|19|04|.08|" data-ref-path="10|19|04|.08" class="h__section">.08 Enforcement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.08#A">A.</span> A health officer or the health officer's designee may investigate conditions relative to the enforcement of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.08#B">B.</span> The person in charge of an establishment shall permit a health officer or health officer's designee to enter an establishment during its business hours for the purpose of determining compliance with this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.08#C">C.</span> When an investigation is made, the health officer or the health officer's designee shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.08#C(1)">(1)</span> Document:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.04.08#C(1)(a)">(a)</span> The result of the investigation on a report form provided by the Department; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.04.08#C(1)(b)">(b)</span> A condition found that is in violation of the provisions of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.08#C(2)">(2)</span> Furnish one copy of the report form to the person in charge of the establishment; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.08#C(3)">(3)</span> Make the completed report form available for public disclosure in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-611" title="">State Government Article, §10-611</a>— 10-628, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.04.09" data-order="|10|19|04|.09|" data-ref-path="10|19|04|.09" class="h__section">.09 Violations and Certification of Correction.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.09#A">A.</span> The health officer or the health officer's designee shall notify the owner of an establishment found in violation of a provision of this chapter or the Act:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.09#A(1)">(1)</span> By certified mail, return receipt requested, bearing a postmark from the United States Postal Service;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.09#A(2)">(2)</span> Of the specific finding and the penalty for the violation as set forth in <a class="internal-link " href="/us/md/exec/comar/10.19.04.10" title=".10 Penalties.">Regulation .10 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.09#A(3)">(3)</span> Of a specific date by which the owner shall correct the violation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.09#A(4)">(4)</span> That if the owner fails to correct the violation by the date specified, or is in violation of another provision of this chapter or the Act at another time, the Secretary may impose a subsequent penalty as set forth in <a class="internal-link " href="/us/md/exec/comar/10.19.04.10" title=".10 Penalties.">Regulation .10 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.09#A(5)">(5)</span> That the owner is entitled to request a hearing under <a class="internal-link " href="/us/md/exec/comar/10.19.04.11" title=".11 Request for Hearing.">Regulation .11 of this chapter</a> on a violation and penalty, as set forth in <a class="internal-link " href="/us/md/exec/comar/10.19.04.10" title=".10 Penalties.">Regulation .10 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.09#B">B.</span> The owner of an establishment shall submit to the health officer a certification of correction within a time frame provided by the local health department that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.09#B(1)">(1)</span> Lists a violation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.09#B(2)">(2)</span> Includes a description of how the correction was accomplished.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.04.10" data-order="|10|19|04|.10|" data-ref-path="10|19|04|.10" class="h__section">.10 Penalties.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.10#A">A.</span> A person who violates a provision of this chapter is subject to the following penalties:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.10#A(1)">(1)</span> A written reprimand by the Secretary for the first violation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.10#A(2)">(2)</span> A civil penalty of $100 for a second violation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.10#A(3)">(3)</span> A civil penalty of $500 for the third violation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.10#A(4)">(4)</span> A civil penalty of $1,000 per violation for each subsequent finding of violation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.10#B">B.</span> The Department shall pay a penalty collected under this regulation to the Cigarette Restitution Fund established under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsf&amp;section=7-317" title="">State Finance and Procurement Article, §7-317, Annotated Code of Maryland</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.04.11" data-order="|10|19|04|.11|" data-ref-path="10|19|04|.11" class="h__section">.11 Request for Hearing.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.11#A">A.</span> In order to preserve a right to a hearing on a violation and penalty of this chapter, a person shall submit a written request to the Department for a hearing, if a hearing is desired, within 10 days of receipt of the notice of violation and penalty.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.11#B">B.</span> In accordance with the Administrative Procedure Act, <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gsg/gsg.pdf" title="">State Government Article, Title 10, Subtitle 2, Annotated Code of Maryland</a>, the Secretary shall provide for a hearing on the violation by referring the matter to the Office of Administrative Hearings.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.11#C">C.</span> The Office of Administrative Hearings shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.11#C(1)">(1)</span> Schedule and conduct the hearing on the violation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.11#C(2)">(2)</span> Render a decision and notify the parties of the decision within 30 days after the hearing.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.04.12" data-order="|10|19|04|.12|" data-ref-path="10|19|04|.12" class="h__section">.12 Waivers.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#A">A.</span> A person may apply to the health officer for a waiver from the application of a specific provision of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#B">B.</span> The Department shall provide a waiver application on the Department's website.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#C">C.</span> An applicant for a waiver shall establish that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#C(1)">(1)</span> Compliance with a specific provision of this chapter would cause undue financial hardship, as defined in §§D and E of this regulation; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#C(2)">(2)</span> The existence of other factors would render compliance with this chapter unreasonable.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#D">D.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.19.04.12#E" title="">§E of this regulation</a>, an undue financial hardship may be found to exist, based on:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#D(1)">(1)</span> An establishment's demonstration that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#D(1)(a)">(a)</span> A reduction occurred of at least 15 percent in gross sales from the sale of food and beverages for a period of 2 consecutive months during which the establishment has operated smoke-free compared to the combined average of gross sales from the sale of food and beverages during the same 2 consecutive month period in the 2 years immediately before smoke-free operation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#D(1)(b)">(b)</span> The establishment's purported reduction in gross sales from the sale of food and beverages has occurred under similar operational conditions, other than the presence of a smoke-free environment, and is not due to other factors; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#D(2)">(2)</span> An establishment's demonstration that the owner is unable to recover the costs associated with a capital improvement project that was initiated before May 17, 2007, and was designed to provide a partial smoke-free environment at the facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#E">E.</span> If an establishment has not operated for a period of 2 years before February 1, 2008, the establishment shall demonstrate the requirement for undue financial hardship as set forth in <a class="internal-link " href="/us/md/exec/comar/10.19.04.12#D(1)" title="">§D(1) of this regulation</a> by comparing a period of 3 consecutive months during which the establishment has operated smoke-free to the same 3 month period of the previous year or if the establishment was not operating at that time, to the 3 month period immediately preceding February 1, 2008.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#F">F.</span> The applicant for a waiver shall demonstrate how, if a waiver would be granted, the applicant will achieve full compliance with the provisions of the Act and this chapter by January 31, 2011.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#G">G.</span> Within 90 days from the receipt of a completed waiver application, the health officer may grant or deny a waiver to one or more specific provisions of this chapter, based on the criteria set forth in this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#H">H.</span> In granting a waiver, the health officer shall specify:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#H(1)">(1)</span> The actions the applicant shall take that will result in the applicant's achievement of full compliance with the provisions of this chapter by January 31, 2011; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#H(2)">(2)</span> Any additional requirements to minimize the adverse effects of the waiver on individuals involuntarily exposed to secondhand smoke.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#I">I.</span> A person may not apply for a waiver after January 31, 2011.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#J">J.</span> A health officer may not grant a waiver after January 31, 2011.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.04.12#K">K.</span> A person may appeal a health officer's waiver denial in the same manner and subject to the same provisions provided for a violation and a penalty in <a class="internal-link " href="/us/md/exec/comar/10.19.04.11" title=".11 Request for Hearing.">Regulation .11 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.19.05" data-order="|10|19|05|" data-ref-path="10|19|05" class="h__chapter">Chapter 05 Flammable Articles</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: June 30, 1978 (5:13 Md. R. 1063)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.05.01" title=".01 Incorporation by Reference.">Regulation .01</a> amended and recodified to Regulations .01 and .02 effective October 23, 1995 (22:21 Md. R. 1616)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, Title 22, Subtitle 4, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.19.05.01" data-order="|10|19|05|.01|" data-ref-path="10|19|05|.01" class="h__section">.01 Incorporation by Reference.</h3>
                <p>Except for the changes shown in <a class="internal-link " href="/us/md/exec/comar/10.19.05.02" title=".02 Definitions.">Regulation .02 of this chapter</a>, all provisions of 16 CFR 1602, 1605, 1608, 1609, 1610, 1611, 1615, 1616, and 1632, are incorporated by reference.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.05.02" data-order="|10|19|05|.02|" data-ref-path="10|19|05|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.05.02#A">A.</span> In the incorporation by reference cited in <a class="internal-link " href="/us/md/exec/comar/10.19.05.01" title=".01 Incorporation by Reference.">Regulation .01 of this chapter</a>, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.05.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.05.02#B(1)">(1)</span> "Act" means the Maryland Flammable Products Act, Health-General Article, Title 22, Subtitle 4, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.05.02#B(2)">(2)</span> "Commission" means the Maryland Department of Health.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.19.06" data-order="|10|19|06|" data-ref-path="10|19|06" class="h__chapter">Chapter 06 Poison Prevention Packaging</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: November 3, 1978 (5:22 Md. R. 1673)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.06.01" title=".01 Incorporation by Reference of Poison Prevention Packaging Regulations.">Regulation .01</a> amended effective January 7, 1991 (17:26 Md. R. 2975)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, Title 22, Subtitle 3, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.19.06.01" data-order="|10|19|06|.01|" data-ref-path="10|19|06|.01" class="h__section">.01 Incorporation by Reference of Poison Prevention Packaging Regulations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.06.01#A">A.</span> All provisions of 16 Code of Federal Regulations, Part 1700, are incorporated by reference, except for the changes shown in <a class="internal-link " href="/us/md/exec/comar/10.19.06.01#B" title="">§B of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.06.01#B">B.</span> Definitions (see 16 CFR 1700, §1700.1).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.06.01#B(1)">(1)</span> "Act" means Child Resistant Packaging of Dangerous Household Substances, Health-General Article, §§22-301 — 22-312, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.06.01#B(2)">(2)</span> "Commission" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.06.01#B(3)">(3)</span> "Dietary supplement" means a vitamin or mineral preparation, or both, offered in tablet, capsule, wafer, or other similar uniform unit form; in powder, granule, flake, or liquid form; or in the physical form of a conventional food but which is not a conventional food; and which purports or is represented to be for special dietary use by humans to supplement their diets by increasing the total dietary intake of one or more of the essential vitamins or minerals, or both.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.19.07" data-order="|10|19|07|" data-ref-path="10|19|07" class="h__chapter">Chapter 07 Prohibition of Child Care Products Containing TCEP or TDCPP</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.07.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.07.04" title=".04 Violations.">.04</a> adopted as an emergency provision effective October 1, 2013 (40:22 Md. R. 1871); adopted permanently effective January 6, 2014 (40:26 Md. R. 2164)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.07.01#A" title="">Regulation .01A</a> amended effective January 19, 2015 (42:1 Md. R. 18)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.07.02#B" title="">Regulation .02B</a> amended effective January 19, 2015 (42:1 Md. R. 18); December 25, 2023 (50:25 Md. R. 1088)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.07.03" title=".03 Prohibition of TCEP or TDCPP in Child Care Products.">Regulation .03</a> amended effective January 19, 2015 (42:1 Md. R. 18)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§24-306 and 24-306.1, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.19.07.01" data-order="|10|19|07|.01|" data-ref-path="10|19|07|.01" class="h__section">.01 Scope.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.07.01#A">A.</span> This chapter establishes regulations that prohibit the import, sale, or offering for sale of child care products containing:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.07.01#A(1)">(1)</span> TCEP, also known as (tris (2-chloroethyl) phosphate); or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.07.01#A(2)">(2)</span> TDCPP, also known as (tris (1, 3-dichloro-2-propyl) phosphate).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.07.01#B">B.</span> This chapter does not apply to the sale or distribution of a child care product that is resold, offered for resale, or distributed by a consumer for consumer use.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.07.02" data-order="|10|19|07|.02|" data-ref-path="10|19|07|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.07.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.07.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.07.02#B(1)">(1)</span> “Child care product” means a consumer product intended for use by a child under the age of 3 years, including a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.07.02#B(1)(a)">(a)</span> Baby product;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.07.02#B(1)(b)">(b)</span> Toy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.07.02#B(1)(c)">(c)</span> Car seat;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.07.02#B(1)(d)">(d)</span> Nursing pillow;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.07.02#B(1)(e)">(e)</span> Crib mattress; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.07.02#B(1)(f)">(f)</span> Stroller.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.07.02#B(2)">(2)</span> “Secretary” means the Secretary of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.07.02#B(3)">(3)</span> “TCEP” means an industrial chemical also known as (tris (2-chloroethyl) phosphate).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.07.02#B(4)">(4)</span> “TDCPP” means an industrial chemical also known as (tris (1, 3-dichloro-2-propyl) phosphate).</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.07.03" data-order="|10|19|07|.03|" data-ref-path="10|19|07|.03" class="h__section">.03 Prohibition of TCEP or TDCPP in Child Care Products.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.07.03#A">A.</span> A person may not import, sell, or offer for sale any child care product containing more than 1/10 of 1 percent of TCEP by mass.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.07.03#B">B.</span> On or after October 1, 2014, a person may not import, sell, or offer for sale any child care product containing more than 1/10 of 1 percent of TDCPP by mass.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.07.03#C">C.</span> The Secretary may suspend implementation of this chapter if the Secretary determines that the fire safety benefits of TCEP or TDCPP are greater than the known health risks associated with TCEP or TDCPP.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.07.04" data-order="|10|19|07|.04|" data-ref-path="10|19|07|.04" class="h__section">.04 Violations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.07.04#A">A.</span> A person that violates this chapter is subject to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.07.04#A(1)">(1)</span> For a first violation, a civil penalty not exceeding $1,000; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.07.04#A(2)">(2)</span> For any subsequent violation, a civil penalty not exceeding $2,500 for each violation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.07.04#B">B.</span> In addition to the civil penalties described in <a class="internal-link " href="/us/md/exec/comar/10.19.07.04#A" title="">§A of this regulation</a>, a court may also enjoin an action prohibited in <a class="internal-link " href="/us/md/exec/comar/10.19.07.04" title=".04 Violations.">Regulation .04 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.19.08" data-order="|10|19|08|" data-ref-path="10|19|08" class="h__chapter">Chapter 08 Prohibition of Consumer Products Containing Flame-Retardant Chemicals</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: December 25, 2023 (50:25 Md. R. 1088)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §24-306.1, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.19.08.01" data-order="|10|19|08|.01|" data-ref-path="10|19|08|.01" class="h__section">.01 Scope.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.01#A">A.</span> This chapter establishes regulations that prohibit the import, sale, or offering for sale of juvenile products, mattresses, upholstered furniture, or reupholstered furniture containing more than 0.1 percent of flame-retardant chemical by mass.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.01#B">B.</span> This chapter does not apply to the sale or distribution of a juvenile product, a mattress, upholstered furniture, or reupholstered furniture that is resold, offered for resale, or distributed by a consumer for consumer use.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.08.02" data-order="|10|19|08|.02|" data-ref-path="10|19|08|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(1)">(1)</span> “Adult mattress” means any mattress other than a toddler mattress, a crib mattress, or any other infant sleep product.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(2)">(2)</span> “Flame-retardant chemical” means a chemical that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(2)(a)">(a)</span> Is used to resist or inhibit the spread of fire or act as a synergist to chemicals that resist or inhibit the spread of fire, including any chemical for which the term “flame retardant” appears on a safety data sheet developed in accordance with 29 CFR §1910.1200(g); and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(2)(b)">(b)</span> Is a nanoscale chemical or has one or more of the following properties:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(2)(b)(i)">(i)</span> Contains one or more halogen elements, including fluorine, chlorine, bromine, or iodine;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(2)(b)(ii)">(ii)</span> Contains one or more carbon elements and one or more phosphorus elements; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(2)(b)(iii)">(iii)</span> Contains one or more carbon elements and one or more nitrogen elements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)">(3)</span> Juvenile Product.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(a)">(a)</span> “Juvenile product” means a consumer product intended for use by a child younger than 12 years old.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)">(b)</span> “Juvenile product” includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(i)">(i)</span> A bassinet;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(ii)">(ii)</span> A booster seat;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(iii)">(iii)</span> A changing pad;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(iv)">(iv)</span> A children’s nap mat;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(v)">(v)</span> A floor playmat;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(vi)">(vi)</span> A high chair;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(vii)">(vii)</span> A high chair pad;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(viii)">(viii)</span> An infant bouncer;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(ix)">(ix)</span> An infant carrier;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(x)">(x)</span> An infant seat;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(xi)">(xi)</span> An infant swing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(xii)">(xii)</span> An infant walker;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(xiii)">(xiii)</span> A nursing pad;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(xiv)">(xiv)</span> A nursing pillow;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(xv)">(xv)</span> A playpen side pad;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(xvi)">(xvi)</span> A play yard;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(xvii)">(xvii)</span> A portable hook-on chair; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(b)(xviii)">(xviii)</span> A stroller.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(c)">(c)</span> “Juvenile product” does not include a:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(c)(i)">(i)</span> Product that is not primarily intended for use in the home, including a product that is, or is a component part of, a motor vehicle, a watercraft, an aircraft, or any other vehicle;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(c)(ii)">(ii)</span> Product regulated under 49 CFR Part 571;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(c)(iii)">(iii)</span> Consumer electronic product; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(3)(c)(iv)">(iv)</span> Child care product regulated under Health-General Article, §24-306, Annotated Code of Maryland, or <a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.07" title="Chapter 07 Prohibition of Child Care Products Containing TCEP or TDCPP">COMAR 10.19.07</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(4)">(4)</span> “Mattress” has the meaning stated in 16 CFR § 1632.1.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(5)">(5)</span> “Reupholstered furniture” means furniture for which the original fabric, padding, decking, barrier material, foam, or other resilient filling has been replaced and that has not been sold since the time of replacement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.02#B(6)">(6)</span> “Upholstered furniture” means furniture that includes filling materials, barrier materials, decking materials, or cover fabrics.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.08.03" data-order="|10|19|08|.03|" data-ref-path="10|19|08|.03" class="h__section">.03 Prohibition of Flame-Retardant Chemicals in Consumer Products.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.03#A">A.</span> This regulation does not apply to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.03#A(1)">(1)</span> An electronic component, or the casing for an electronic component, of a juvenile product, a mattress, upholstered furniture, or reupholstered furniture;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.03#A(2)">(2)</span> A component of upholstered or reupholstered furniture other than cover fabric, barrier material, resilient filling material, and decking material;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.03#A(3)">(3)</span> Thread or fiber when used for stitching mattress components together; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.03#A(4)">(4)</span> Except for foam, a component of an adult mattress.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.03#B">B.</span> A person may not import, sell, or offer for sale any juvenile product, mattress, upholstered furniture, or reupholstered furniture that contains more than 0.1 percent of flame-retardant chemicals by mass.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.08.04" data-order="|10|19|08|.04|" data-ref-path="10|19|08|.04" class="h__section">.04 Complaints and Investigations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.04#A">A.</span> The Secretary or the Secretary’s designee may investigate conditions relative to the enforcement of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.04#B">B.</span> The person in charge of an establishment shall permit the Secretary or the Secretary’s designee to enter an establishment during its business hours for the purpose of determining compliance with this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.04#C">C.</span> The person in charge of an establishment shall provide to the Secretary or the Secretary’s designee product safety data sheets, technical specifications, and any information available related to the composition of the juvenile product.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.08.05" data-order="|10|19|08|.05|" data-ref-path="10|19|08|.05" class="h__section">.05 Violations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.05#A">A.</span> If a person willfully violates this chapter, the Secretary may assess a civil penalty:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.05#A(1)">(1)</span> For a first violation after receiving a letter of reprimand, not exceeding $2,500;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.05#A(2)">(2)</span> For a second violation, not exceeding $5,000;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.05#A(3)">(3)</span> For a third violation, not exceeding $7,500; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.05#A(4)">(4)</span> For any subsequent violation, not exceeding $10,000 for each violation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.05#B">B.</span> In determining the amount of a penalty under <a class="internal-link " href="/us/md/exec/comar/10.19.08.05#A" title="">§A of this regulation</a>, the Secretary shall consider:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.05#B(1)">(1)</span> The nature and severity of the violation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.05#B(2)">(2)</span> The good faith of the person;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.05#B(3)">(3)</span> The history of violations by the person;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.05#B(4)">(4)</span> The extent to which the person cooperated with any investigation by the Department; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.05#B(5)">(5)</span> Whether the person has previously been issued a letter of reprimand.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.05#C">C.</span> For a violation of this chapter, the Secretary shall issue a letter of reprimand.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.19.08.06" data-order="|10|19|08|.06|" data-ref-path="10|19|08|.06" class="h__section">.06 Request for Hearing.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.06#A">A.</span> In order to preserve a right to a hearing on a violation and penalty of this chapter, a person shall submit a written request to the Department for a hearing, if a hearing is desired, within 10 days of receipt of the notice of violation and penalty.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.06#B">B.</span> In accordance with the Administrative Procedure Act, <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gsg/gsg.pdf" title="">State Government Article, Title 10, Subtitle 2, Annotated Code of Maryland</a>, the Secretary shall provide for a hearing on the violation by referring the matter to the Office of Administrative Hearings.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.19.08.06#C">C.</span> The Office of Administrative Hearings shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.06#C(1)">(1)</span> Schedule and conduct the hearing on the violation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.19.08.06#C(2)">(2)</span> Render a decision and notify the parties of the decision within 30 days after the hearing.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.18" aria-label="Subtitle 18 HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)">
                <div class="h__ui">Previous</div>
                <span>Subtitle 18 HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.20" aria-label="Subtitle 20 KIDNEY DISEASE PROGRAM">
                <div class="h__ui">Next</div>
                <span>Subtitle 20 KIDNEY DISEASE PROGRAM</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC-BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
